Liberty Wealth Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,267
| Closed | -$12.9K | – | 234 |
|
|
2025
Q1 | $12.9K | Hold |
1,267
| – | – | ﹤0.01% | 154 |
|
|
2024
Q4 | $17.7K | Hold |
1,267
| – | – | ﹤0.01% | 225 |
|
|
2024
Q3 | $25K | Hold |
1,267
| – | – | ﹤0.01% | 224 |
|
|
2024
Q2 | $24K | Hold |
1,267
| – | – | ﹤0.01% | 223 |
|
|
2024
Q1 | $18K | Hold |
1,267
| – | – | ﹤0.01% | 185 |
|
|
2023
Q4 | $11K | Hold |
1,267
| – | – | ﹤0.01% | 169 |
|
|
2023
Q3 | $11K | Hold |
1,267
| – | – | ﹤0.01% | 174 |
|
|
2023
Q2 | $10.9K | Hold |
1,267
| – | – | ﹤0.01% | 191 |
|
|
2023
Q1 | $13.4K | Buy |
+1,267
| New | +$13.4K | ﹤0.01% | 229 |
|
|
2022
Q3 | $61K | Hold |
1,275
| – | – | 0.02% | 149 |
|
|
2022
Q2 | $72K | Hold |
1,275
| – | – | 0.03% | 149 |
|
|
2022
Q1 | $103K | Hold |
1,275
| – | – | 0.04% | 158 |
|
|
2021
Q4 | $258 | Hold |
1,275
| – | – | 0.01% | 132 |
|
|
2021
Q3 | $343K | Hold |
1,275
| – | – | 0.12% | 106 |
|
|
2021
Q2 | $328K | Buy |
1,275
+8
| +0.6% | +$2.06K | 0.13% | 90 |
|
|
2021
Q1 | $393K | Hold |
1,267
| – | – | 0.19% | 74 |
|
|
2020
Q4 | $393K | Buy |
1,267
+334
| +36% | +$104K | 0.19% | 74 |
|
|
2020
Q3 | $232K | Hold |
933
| – | – | 0.14% | 82 |
|
|
2020
Q2 | $324K | Hold |
933
| – | – | 0.23% | 67 |
|
|
2020
Q1 | $250K | Buy |
+933
| New | +$250K | 0.22% | 70 |
|
|
2019
Q4 | – | Sell |
-191
| Closed | -$52K | – | 946 |
|
|
2019
Q3 | $52K | Buy |
191
+178
| +1,369% | +$48.5K | 0.05% | 224 |
|
|
2019
Q2 | $7K | Buy |
+13
| New | +$7K | 0.01% | 597 |
|